title: FGFR3 dysregulation and clinical outcome in myeloma.
authors.forename: Thomas
authors.initials: T
authors.lastname: Rasmussen
authors.forename: Heidi Rye
authors.initials: HR
authors.lastname: Hudlebusch
authors.forename: Lene Meldgaard
authors.initials: LM
authors.lastname: Knudsen
authors.forename: Hans Erik
authors.initials: HE
authors.lastname: Johnsen
mesh_terms: D002883:Chromosomes, Human, Pair 14; D002894:Chromosomes, Human, Pair 4; D018450:Disease Progression; D005819:Genetic Markers; D020022:Genetic Predisposition to Disease; D006801:Humans; D009101:Multiple Myeloma / Q000235:genetics*; D010265:Paraproteinemias / Q000235:genetics; D011505:Protein-Tyrosine Kinases; D051498:Receptor, Fibroblast Growth Factor, Type 3; D017468:Receptors, Fibroblast Growth Factor / Q000235:genetics*; D014178:Translocation, Genetic
chemical_list: D005819:Genetic Markers; D017468:Receptors, Fibroblast Growth Factor; C496365:FGFR3 protein, human; D011505:Protein-Tyrosine Kinases; D051498:Receptor, Fibroblast Growth Factor, Type 3